Praxis Precision Medicines, Inc.
PRAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $7,463 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $65,797 | $63,006 | $60,806 | $56,288 |
| Gross Profit | -$65,797 | -$63,006 | -$60,806 | -$48,825 |
| % Margin | – | – | – | -654.2% |
| R&D Expenses | $65,797 | $63,006 | $60,806 | $56,288 |
| G&A Expenses | $12,562 | $13,061 | $13,922 | $15,131 |
| SG&A Expenses | $12,562 | $13,061 | $13,922 | $15,131 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$65,797 | -$63,006 | -$60,806 | -$56,288 |
| Operating Expenses | $12,562 | $13,061 | $13,922 | $15,131 |
| Operating Income | -$78,359 | -$76,067 | -$74,728 | -$63,956 |
| % Margin | – | – | – | -857% |
| Other Income/Exp. Net | $4,425 | $4,940 | $5,432 | $5,277 |
| Pre-Tax Income | -$73,934 | -$71,127 | -$69,296 | -$58,679 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$73,934 | -$71,127 | -$69,296 | -$58,679 |
| % Margin | – | – | – | -786.3% |
| EPS | -3.36 | -3.31 | -3.29 | -2.94 |
| % Growth | -1.5% | -0.6% | -11.9% | – |
| EPS Diluted | -3.36 | -3.31 | -3.29 | -2.94 |
| Weighted Avg Shares Out | 21,977 | 21,475 | 21,056 | 19,980 |
| Weighted Avg Shares Out Dil | 21,977 | 21,475 | 21,056 | 19,980 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $4,940 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $19 | $46 | $47 | $47 |
| EBITDA | -$73,915 | -$76,021 | -$74,681 | -$63,909 |
| % Margin | – | – | – | -856.3% |